Our experience in the use of Mexidol in the complex treatment of patients with primary open -angle glaucoma

Authors:
E.A. Afonina, M.A. Levko, L.V. Chekurova, T.I. Kosacheva

SZGMU them. I.I. Mechnikov, St. Petersburg

Place of publication:
Russian Glack School, Glaucoma Conference Theory and Practice. No. 8, 2013, p. 33-37.

Summary:
Purpose of the study. To study the effectiveness of the drug Mexidol in the complex treatment of primary open -angle glaucoma. Materials and methods. The study included patients from 55 to 75 years with a diagnosis of signs I-III Art. on both eyes, with a normalized level of IOA (not more than 21 mm Hg according to Goldman); not having a serious ophthalmic and general somatic pathology that affects the course and results of the study; Benzodiazepine anxiolytics, anticonvulsant and anti -parquinsole drugs that do not use as concomitant therapy, as well as the last 3 months that do not participate in another clinical study.